The stage of changes has arrived Novo Nordsk. The actual CEO, Lars Fruergaard Jhyrgensen, Ha Dimitido Traas La “Decrease in the stock price” From the company. This was announced by the Danish company, which dealt for several months with the arrival of drugs against the obesity that competes directly with it Medicina ‘Estrella’and Ozambi. Likewise, the pharmacist added details about the caliphate process, as well as in the future of J Prietensen itself.
Novo Nordisk announced that this change in the board of directors is a “mutual agreement”. “Given the recent market challenges, It decreases in the stock price (This touch 53 percent) and the desire for the foundation Novo NordskThe company statement says: “Novo Nordsk and Lars Farrdard Jurgenin, in association, have completed that the start of the CEO of the company is the best for the company and its shareholders,” the company’s statement said.
In this way, the Danish company also indicates this Yurgnessen “Liquid transmission” will facilitate the arrival Your successor. Finally, in addition, Novo Nordisk indicated that there is no name on the table. The company says: “It is searched for and referred to in a timely manner,” the company says.
Changes in Novo Nordisk
the The resignation of the current CEO It is not the only change that will occur in the directional dome of the pharmaceutical company. In this sense, the company also mentioned this Lars Ripan SorensenThe president of the Novo Nordisk Foundation will join the Novo Nordisk board as a “observer”. All this “with the intention of nominating the elections as a member in The Council at the annual General Assembly of 2026“.
La trayctoria de lars Fruergaard jditionsen
You have to return to the year 1991 To draw the arrival of Laars Frued Jägensen to Novo Nordisk. It was 34 years ago, when the current CEO arrived at the pharmaceutical company. Years later, in 2017, the company’s executive director was appointed that in recent years he became a pioneer in Drugs for obesity.
Eight years later in one of the maximum jobs DomeJoerginson says, “Goodbye” to the company he was during most of his career. The company will take the next step, which will announce the new CEO who will try to improve the company’s economic rates.
The information published in the medical writing contains data, data and data from official institutions and health professionals. However, given any questions related to your health, consult the opposite health specialist.
